MetaCap

Adagene Insider Trades

NASDAQ: ADAGHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.76-0.25 (-12.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $162.24K
Sales
0 · $0
Shares bought / sold
47.53K / 0
Net activity
Net buying $162,244

Adagene insider activity

Over the last 12 months, Adagene insiders reported 5 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $162,244 and sold $0 worth of stock, for net insider buying of $162,244. The most recent filing shows Tam Man Kin (Chief Financial Officer) buying 2,000 shares at $3.00 on Sep 23, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ADAG's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ADAG insider transactions

Adagene insider transactions
DateInsiderTypeSharesValueFiling
Sep 23, 2026Tam Man KinChief Financial OfficerBuy2,000$6.00KForm 4
Sep 16, 2026Luo PeterChief Executive OfficerBuy20,290$63.98KForm 4
Aug 14, 2026DO CUONG VDirectorBuy2,000$7.50KForm 4
Aug 5, 2026Luo PeterChief Executive OfficerBuy279$1.02KForm 4
Aug 4, 2026Luo PeterChief Executive OfficerBuy22,966$83.75KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related